BOT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Botanix Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 0.021 AUD -12.5% Market Closed

Market Cap: AU$57.4m

	Botanix Pharmaceuticals Ltd ASX:BOT	AU
H	Healthcare Co Ltd SSE:603313	CN

Profitability Summary

Botanix Pharmaceuticals Ltd's profitability score is 17/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

61%

Negative 3Y Average Gross Margin

-5%

Gross Margin is Increasing

11% > 61%

Negative Operating Margin

-409%

Negative 3Y Average Operating Margin

-3 184%

Operating Margin is Increasing

-4 399% > -409%

Negative Net Margin

-405%

Negative 3Y Average Net Margin

-3 200%

Net Margin is Increasing

-2 804% > -405%

Negative Free Cash Flow Margin

-358%

Negative 3Y Average Free Cash Flow Margin

-4 860%

Free Cash Flow Margin is Increasing

-5 059% > -358%

Negative ROE

-121%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-126%

ROIC is Increasing

-406% > -174%

View All

Hide

Collapse

17 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.